Discover Great Companies Discover Great Clients
Popularity  12.1万   |   Followers  33   |   Likes  66   |   Feedback  37 Claim this company
No.92 Changsha City Popularity Ranking No.25 Yuelu District No.131 Hunan Prov No.1 Chinese Patent Medicines No.1 Chinese Medicinal Materials No.1 Antibiotics No.1 Chemistry APIs No.1 Chemistry Pharmaceuticals No.2 Zhi Wu Ti Qu No.2 Ti Qu Products No.2 Pharmaceutical APIs No.2 Pharmaceutical Intermediates No.2 APIs No.3 Pharmaceutical Technology No.3 Biopharmaceuticals 博士后工作站 高新技术企业 绿色工厂 省级专精特新中小企业 企业技术中心 省著名商标 GMP认证
More

Company Overview

  • Nature: Listed Company Size: 500-999 employees Founded: 25年
  • Industry: Pharmaceutical/Biotechnology 、 Raw Material and Processing
  • Full name: Hunan Warner Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: IPO上市, , 上交所。
  • Ranking: Ranked #92 in Changsha City by popularity Ranked #1 in Changsha Chinese Patent Medicines Company by popularity Ranked #1 in Changsha Chinese Medicinal Materials Company by popularity Ranked #1 in Changsha Antibiotics Company by popularity Ranked #1 in Changsha Chemistry APIs Company by popularity
  • Honors: 2025中国化药研发实力100强 博士后工作站 高新技术企业 According to algorithm
  • News: 2026-08-31:华纳药厂:洛索洛芬钠贴剂获得药品注册证书。
  • Salary: 80.3% of positions earn 6-15K, In 2026 vs last yeardecreased by 9%.。Master's salary: ¥14.4K, Doctorate salary: ¥25.0K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 27.1%, "Other (R&D and Technical)": 19.1%, "Medical & Health/Beauty & Healthcare": 14.9%。
  • Recruiting: In 2026 vs 2025decreased by 11%. Demand for highly educated talent: Master's: 4, Doctorate: 4.
  • Requirement: Education: 本科 leads with 61.7%. Experience: 不限 leads with 37.8%.
  • Region: Distributed across 1 regions, 长沙: 95.7%, 成都: 1.7%, 太原: 0.9%, 重庆: 0.9%.

About the Company

Warner Pharmaceutical is a pharmaceutical manufacturer listed on the STAR Market of the Shanghai Stock Exchange (stock code: 688799), with R&D innovation as its guiding principle and high-end chemical drugs and traditional Chinese medicine research, development, production, and sales as its main business. The company adheres to the corporate mission of "Serving Health through Science and Technology" and follows the business philosophy of "Dedicated to Pharmaceuticals, Honest in Dealing with People," focusing single-mindedly on expanding its core business. It has progressively established a R&D system covering everything from new product ideation, research, and registration to industrialization, and has built three production bases: a chemical API base, a chemical drug formulation base, and a botanical extract raw material and proprietary Chinese medicine base, distributed across the Wangcheng Economic Development Zone and the Liuyang Economic Development Zone in Hunan. It also maintains a distribution network that broadly covers tertiary hospitals, primary healthcare institutions, and OTC terminals. This has formed two complete industrial chains—"from chemical APIs to chemical drug formulations" and "from traditional Chinese medicine pre-processing, extraction, and separation to proprietary Chinese medicines"—with continuously strengthened internal collaboration and supporting capabilities between R&D and industrialization. Through collaborative platforms such as postdoctoral workstations, industry-university-research joint laboratories, and a chiral drug engineering center, the company has achieved close cooperation with scientific research institutions including Central South University, Hunan University, and the Beijing Institute of Pharmacology of the Chinese Academy of Medical Sciences, thereby advancing the initiation and development of innovative drugs, improved new drugs, and generic drugs. The six core technology platforms, exemplified by bismuth preparations and pellets, continue to accumulate high-end talent, technology, and products, maintaining a leading level of new drug development projects. With coordinated development across R&D, production, and sales, revenue and profits have maintained rapid and stable growth. In the future, the company will strengthen its talent recruitment, training, reserve, and incentive strategies, continuously improve the performance evaluation and internal promotion mechanisms for R&D technical personnel, professional management staff, and market service personnel, and build a clear, transparent internal talent development pathway to progressively optimize the age and professional structure of its core talent. Thus, with abundant human resource reserves, the company aims to establish marketing service advantages in market segments through its product cluster strengths, and build cost and quality advantages in integrated APIs and formulations through its technological and product integration strengths, creating a first-class domestic high-end chemical drug industrialization platform with international market competitiveness. It will also leverage distinctive traditional Chinese medicines, such as substitutes for endangered animal medicinal materials and botanical extract raw materials, as entry points to build a specialized innovative traditional Chinese medicine industrialization platform. The company is committed to becoming a branded, reputable, and trustworthy supplier of health products.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Warner Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

Warner Pharmaceutical How Fast Is Hiring Growing? (108 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 41%
  • 2024: Up 30%
  • 2023: Up 70%
  • 2022: Down 73%
Warner Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Warner Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 6 Interns 1 Master's 4 Doctorate 4
No.60
Company Recruitment Ranking in Changsha City 򀀩
No.1398
Recruitment Growth Ranking in Changsha City 򀀩
No.33
Graduate Talent Ranking in Changsha City 򀀩
No.133
Intern Talent Ranking in Changsha City 򀀩
Note: How fast is hiring at Hunan Warner Pharmaceutical Co., Ltd. growing? Warner Pharmaceutical2026: 168 openings (down 11%), 2025: 188 openings (up 41%), 2024: 133 openings (up 30%), 2023: 102 openings (up 70%), 2022: 60 openings (down 73%), 2021: 224 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Warner Pharmaceutical Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Hunan Warner Pharmaceutical Co., Ltd. growing? . Warner Pharmaceutical master talent ranking in Changsha: #150, Warner Pharmaceutical master salary mostly around 10-20K.

Warner Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
-30%
Growth Rate
2026 vs 2025
  • 2025: Up 67%
  • 2022: Up 100%
Warner Pharmaceutical Doctoral Hiring by Year: 2026 — 3 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.16
Doctoral Demand Ranking in Changsha City 򀀩
¥15-30K
Doctoral Salary 򀀩
How fast is doctoral hiring at Hunan Warner Pharmaceutical Co., Ltd. growing? Warner PharmaceuticalDoctorate recruitment over the years: 2026: 7 openings (down 30%), 2025: 10 openings (up 67%), 2024: 6 openings, 2022: 2 openings (up 100%), 2021: 1 openings. Warner Pharmaceutical doctorate talent ranking in Changsha: #16, Warner Pharmaceutical doctorate salary mostly around 15-30K.

Warner Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Hunan Warner Pharmaceutical Co., Ltd.? Based on an analysis of Warner Pharmaceutical's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 27.1%, "Other (R&D and Technical)": 19.1%, "Medical & Health/Beauty & Healthcare": 14.9%, "Scientific Research": 8%, "Mechanical/Instrumentation": 6.9%, "Computer/Network/Technology": 4.8%. For reference only.

Warner Pharmaceutical — What Are the Salaries Like? (188 records)

Manage
salary range: 4.5K - 50K, 80.3% of roles pay ¥6-15K
Note: salary statistics are based on 188 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Hunan Warner Pharmaceutical Co., Ltd.?Warner Pharmaceutical80.3% of positions earn 6-15K, Fresh graduate salary: ¥16.0K。Changsha salary ranking top 45,生物/制药/化工/环保类 average salary ¥10.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Warner Pharmaceutical

(More)
Are salaries high at Hunan Warner Pharmaceutical Co., Ltd.? We provide: Researcher, Accountant, Analyst, Workshop, Leasing Manager, Quality, Equipment Operator, Acceptance Inspector, Process Technician, Assistant Manager, Data Engineer, Equipment Technician, Equipment Management Specialist, Procurement, QA, QC, Sales Representative, Product Specialist, Information, 外贸业务. Click to view detailed salary analysis by job.

Warner Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国化药研发实力100强:

  • NO.78 2025中国化药研发实力100强 >

Warner Pharmaceutical honors, qualifications & industry associations

Job Category

  • 生物/制药/化工/环保类
    26.1% of total 26.1%
  • 其他(研发和技术类)
    17.8% of total 17.8%
  • 医疗卫生/美容保健类
    17.4% of total 17.4%
  • 在校学生类
    17.4% of total 17.4%

Education

  • 本科
    61.7% of total 61.7%
  • 不限
    17.4% of total 17.4%
  • 大专
    10.9% of total 10.9%
  • 硕士
    4.3% of total 4.3%

Experience

  • 不限
    37.8% of total 37.8%
  • 1-3年
    23.9% of total 23.9%
  • 3-5年
    19.6% of total 19.6%
  • 5-10年
    13% of total 13%
View Detailed Analysis

What does Hunan Warner Pharmaceutical Co., Ltd. require? Who is Warner Pharmaceutical hiring? Warner Pharmaceutical recruitment: 生物/制药/化工/环保类占比最多占26.1%,其次是其他(研发和技术类)占17.8%. What education can get in at Warner Pharmaceutical? 本科占比最多占61.7%,其次是不限占17.4%. High education required at Warner Pharmaceutical? 硕士占4.3%,博士占3.9%. Work experience required at Warner Pharmaceutical? 不限占比最多占37.8%,其次是1-3年占23.9%. Where are the job locations at Warner Pharmaceutical? 长沙占比最多占95.7%,其次是成都占1.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 13,132万(元)
Legal Representative: 黄本东
Date Established:
Credit Code: 914301007279773228
Registered Address: 湖南浏阳生物医药园区

Partners & Suppliers

首次公开发行股票并上市的保荐机构,持续督导 Source
供应商 投资银行服务
年度财务报表及内控审计机构 Source
供应商 审计服务
2023年度第二大供应商,提供药用辅料 Source
供应商 药用辅料
2023年度第五大供应商,提供原料药 Source
供应商 原料药
2023年度第四大供应商,提供化工原料 Source
供应商 原料药

People who follow Warner Pharmaceutical also follow

Warner Pharmaceutical Competitors (Similar Companies)

“Hunan Province Top Ten Pharmaceutical Industry Enterprises”
“Biological diagnostic reagents and pharmaceuticals”
“Home furnishing brand operator”
制冷 压缩机 精密铸造 空调压缩机
“Top 10 of China Light Industry Plastic Industry”
“Professional manufacturer and service provider of cranes”
“电连接器、连接器组件及精密智能产品”
“International engineering general contracting, import and export trade”
“一家以先进制造业为核心的国际化公司”
药品零售 大健康 医药工业 医药流通
“主营医药中间体、原料药和成品药的研发、生产与销售”
“A large joint-stock listed enterprise mainly engaged in the manufactur”
“Love Life, Love Lafang”
“Let every Chinese family enjoy the care of professional home medical c”
创新服务 网络科技 IT服务 运维/运营维护

Discover Great Companies, Discover Great Clients

长沙公司名录 长沙“Yuelu District”公司名录 长沙“制药/药业”公司名录 长沙“生物医药”公司名录 长沙“抗生素”公司名录 长沙“化工/化学原料”公司名录 长沙“医药中间体”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates